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Background. Weight is typically measured on a single day in research studies. This practice assumes negligible day-to-day weight
variability, although little evidence exists to support this assumption. We compared the precision of measuring weight on one
versus two days among control participants in the Weight Loss Maintenance trial. Methods. Trained staﬀ measured weight on two
separate days at baseline, 12 months, and 30 months (2004–2007). We calculated the standard deviation (SD) of mean weight
change from baseline to the 12- and 30-month visits using (a) the ﬁrst and (b) both daily weights from each visit and conducted a
variance components analysis (2009). Results. Of the 316 participants with follow-up measurements, mean (SD) age was 55.8 (8.5)
years, BMI was 30.8 (4.5)kg/m2, 64% were women, 36% were black, and 50% were obese. At 12 months, the SD of mean weight
change was 5.1versus 5.0kg using one versus two days of weight measurements (P = .76), while at 30 months the corresponding
SDs were 6.3 and 6.3kg (P = .98). We observed similar ﬁndings within subgroups of BMI, sex, and race. Day-to-day variability
within individuals accounted for <1% of variability in weight. Conclusions. Measurement of weight on two separate days has no
advantage over measurement on a single day in studies with well-standardized weight measurement protocols.
1.Introduction
Short- and long-term variability in outcomes can aﬀect
power in research studies. Weight is usually measured on
a single day per study visit (i.e., time point in study:
baseline and followup) in clinical trials of weight loss
or maintenance. However, day-to-day variability in weight
within an individual may decrease precision, thus impacting
necessary sample sizes. Because of this type of variability in
blood pressure, sample size is optimized by using at least 3
sets of daily blood pressure measurements per study visit [1].
We aimed to evaluate the hypothesis that measurement
of weight on one day is suﬃciently precise compared to
two days by (1) comparing the standard deviation of weight
change based on one versus two days of measurements and
(2) evaluating components of weight variability using data
from the Weight Loss Maintenance (WLM) Trial [2].
2. Methods
2.1. Study Design. WLM was an NHLBI-supported, 4-site,
and randomized controlled trial comparing 2 weight loss
maintenance interventions to a self-directed control group
in two phases: an initial 6-month weight-loss phase common
to all participants (phase 1) and a randomized, 30-month
weight-maintenance phase (phase 2). This study uses data2 Journal of Obesity
from phase 2. Data collection occurred between 2004 and
2007. Methods and results have been published previously
[2–4]. Participants had a body mass index (BMI) between
25 and 45kg/m2, treated hypertension, hyperlipidemia, or
both, access to a telephone and the Internet, no active
cardiovascular disease, diabetes, or medical condition(s)
precluding participation, absence of >9kg weight loss in
the prior 3 months, no use of weight loss medication, and
no history of weight loss surgery [2]. Participants provided
informed consent, and institutional review boards at each
study site approved the protocol [2]. Participants were
eligible for phase 2 if they lost ≥4kg during the initial weight
loss phase [2].
The current study is limited to the 316 (out of 342)
control group participants who attended either the 12- or
30-month follow-up visits in phase 2. This group received
printed lifestyle guidelines (for diet and physical activity)
while meeting with an interventionist at randomization [3]
and after the 12-month visit [2].
2.2. Study Measurements. Weight was measured during
screening, at the conclusion of phase 1 (baseline), and at
12- and 30-month postrandomization into phase 2. Height
was measured once during screening. Trained and certiﬁed
staﬀ used high-quality calibrated digital scales and calibrated
stadiometers, and participants wore light clothes and no
shoes [2].
On any given day, weight was measured as the average of
two independent measurements. For the baseline and for the
12- and 30-month visits, this process was repeated on two
separate days (day 1 and day 2). At baseline, these repeated
measurements could have been separated by as much as
32 days, and for purposes of this analysis, we restricted
participants to those individuals whose baseline weight
measures were within 21 days apart from each other. Only 5
(1.6%) out of a possible 314 participants were excluded from
the 12-month analysis for this reason, and only 4 (1.4%)
out of a possible 285 participants were excluded from the
30-month analysis. Because the baseline weights were taken
during the period of active weight loss intervention when
the cohort as a whole was still losing weight, we adjusted
the initial (day 1) weights to have the same mean as the
ﬁnal weights (day 2) by adding to each person’s day-1 weight
the mean change in weight across all participants between
day 1 and 2. For the 12- and 30-month visits, adjustment
for temporal drift between days 1 and 2 was not needed
since participants were not undergoing an active weight loss
intervention. The mean diﬀerences in the two weights at 12-
and 30-months were −0.02 and −0.03kg, respectively.
Participants were not required to fast, and weight mea-
surement did not occur at a speciﬁc time of day. However,
each participant was required to present in a fasting state for
at least one day per visit which included laboratory testing;
this visit would likely occur in the morning.
2.3. Statistical Methods. Analyses were completed using SAS
9.2. Using (a) the ﬁrst and (b) both daily weights from
each visit, we calculated the mean and variance in weight
change from baseline to 12 months and from baseline to
30 months. We deﬁned the variance in weight change as
the standard deviation of weight change and used F-tests
to compare them. We conducted similar analyses stratiﬁed
by screening BMI (25–29.9kg/m2 and ≥30kg/m2), sex, and
race(AfricanAmericanandnon-AfricanAmerican).Wealso
conducted a nested analysis of variance to estimate between-
person,between-visit,andday-to-day(within-visit)variabil-
ity in weight. Within-day variability was not assessed, but
was negligible. A P value <.05 was considered statistically
signiﬁcant. Analyses were performed in 2009.
3. Results
Mean (SD) age was 55.8 (8.5) years, and mean (SD) BMI
was 30.8 (4.5)kg/m2; 64% of participants were women; 36%
were African American; 50% were obese (Table 1). The
mean number of days between day 1 and day 2 of weight
measurement for at the baseline, 12-month, and 30-month
visits was 8.9, 9.1, and 10.4, respectively.
Although the standard deviation of weight change dif-
fered for measurements taken 12 and 30 months apart, it
was essentially unchanged regardless of whether weight was
measured as the mean of one or two days of measurements
(Table 1). For example, the standard deviation for 30-month
weightchangeforallparticipantswas6.3kgwhenweightwas
measured on a single day (day 1) and 6.3kg when weight
was measured on two separate days (days 1 and 2, P = .98).
We found no statistically signiﬁcant diﬀerences overall or in
any of the subgroups studied. Day-to-day variability (i.e.,
of mean change in weight from a single day compared to
that using both day 1 and 2 of the visits) within individuals
accounted for <1% of total variability in weight, while
between-visit variability within individuals accounted for 6–
17% of the variability in weight change depending on the
subgroup (Table 1).
4. Discussion
In the context of this study being conducted with a rigorous
weight measurement protocol, the use of one versus two
measurementdaysperstudyvisit(timepoint)hadessentially
no impact on the variability of weight change in adults
measured over 12 and 30 months, and day-to-day variability
in weight correspondingly accounted for less than 1% of the
total variability in weight.
A limitation of the study is that the baseline weights
were measured while the participants were still engaged in
an active weight-loss intervention. We minimized the added
variability in weight caused by this by adjusting for temporal
driftandbyonlyincluding participantswith21orfewerdays
between day 1 and 2 measurements at the baseline visit. Also,
we evaluated the contribution of day-to-day variability in
weighttovariabilityinweightchangeover12and30months.
Day-to-day variability in weight may be of more signiﬁcance
in shorter studies thus limiting the generalizability of our
results to studies brief in duration.Journal of Obesity 3
Table 1: Mean weight change (standard deviation) and weight variability among control participants in weight loss maintenance
a.
All Overweight
b Obese
c Men
d Women
d African Non-African
american
d americand
N 316 134 158 113 203 113 203
Baseline characteristics
Mean age (SD), years 55.8 (8.5) 57.3 (8.2) 54.9 (8.4) 56.6 (8.6) 55.4 (8.5) 53.5 (9.0) 57.1 (8.0)
% Female 64.2 61.9 67.1 0 100 71.7 60.1
% African American 35.8 26.9 44.9 28.3 39.9 100 0
% Overweight 42.4 100 0 45.1 40.9 31.9 48.3
% Obese 50 0 100 46 52.2 62.8 42.9
Mean BMI (SD), kg/m2 30.8 (4.5) 27.7 (1.4) 34.5 (3.2) 30.3 (4.1) 31.2 (4.7) 32.1 (4.9) 30.1 (4.1)
Mean weight, kg 86.9 (15.0) 78.4 (8.8) 96.6 (13.4) 94.7 (15.1) 82.5 (13.1) 89.5 (15.9) 85.4 (14.3)
N for 12-month analysis 309 131 155 109 200 110 199
12-Month weight Δ (SD), kg
Single day 3.9 (5.1) 3.5 (4.3) 4.5 (5.7) 3.9 (5.8) 3.9 (4.6) 3.6 (4.4) 4.0 (5.4)
Two days 3.9 (5.0) 3.5 (4.2) 4.5 (5.7) 3.9 (5.8) 3.9 (4.5) 3.6 (4.4) 4.1 (5.3)
N for 30-month analysis 281 116 141 104 177 101 180
30-Month weight Δ (SD), kg
Single day 6.0 (6.3) 5.7 (5.1) 6.4 (7.4) 6.7 (8.0) 5.5 (5.0) 5.4 (5.0) 6.2 (6.9)
Two days 6.0 (6.3) 5.8 (5.0) 6.4 (7.4) 6.6 (8.1) 5.6 (4.9) 5.4 (5.0) 6.3 (6.9)
% Total variance
Between-individual, % 91.3 82.4 86.7 88.9 90.7 93.5 89.9
Between-visit, % 8.5 17.1 13 10.9 9 6.3 9.9
Within-visit, % 0.2 0.4 0.3 0.2 0.2 0.2 0.2
SD: standard deviation; kg: kilograms; BMI: body mass index
aP values > .70 for all F-tests comparing standard deviations within each group (e.g., for all participants, comparing SD of mean weight change at 30 months
using a single day (6.3kg) to that using 2 days (6.3kg), P value = .98).
bBMI 25–29.9kg/m2
cBMI ≥ 30kg/m2
dBMI ≥ 25kg/m2.
To our knowledge, this is the ﬁrst study of its kind
to evaluate day-to-day variability in weight as it applies
to measurement in clinical studies. Especially pertinent is
our subgroup analysis showing the stability of day-to-day
weight variability across subgroups deﬁned by BMI, sex, and
race. Finally, WLM used a stringent weight measurement
protocol that included calibrated digital scales, trained
staﬀ, and duplicate within-day measurements to minimize
the probability of measurement or transcription error [2].
Observed day-to-day variability could be expected to be
greater in studies with less stringent weight measurement
protocols, though our ﬁndings would suggest such increased
variability would likely be due to measurement error rather
than to true day-to-day variability.
In conclusion, we show that in the setting of a well-
standardized weight measurement protocol with negligible
measurement error, there is little day-to-day variability in
weight. Weight measurement on a single day is suﬃciently
precise for use in a clinical trial.
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